Features of portal hypertension are associated with major adverse events in Fontan patients: The VAST studyRobert W. Elder, Wendy Book, Nancy McCabe et al.|International Journal of Cardiology|2013Cited by 208
Total Serum Bilirubin within 3 Months of Hepatoportoenterostomy Predicts Short-Term Outcomes in Biliary AtresiaBenjamin L. Shneider, Emily Elgert, John C. Magee et al.|The Journal of Pediatrics|2015Cited by 146
Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA studyShannon M. Vandriel, Catherine Larson‐Nath, Étienne Sokal et al.|Hepatology|2022Cited by 91
Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALABettina E. Hansen, Shannon M. Vandriel, Pamela Vig et al.|Hepatology|2023Cited by 33
Clinical features and natural history of 1154 Alagille syndrome patients: results from the international multicenter GALA study groupShannon M. Vandriel, Pınar Bulut, Liting Li et al.|Journal of Hepatology|2020Cited by 10